ARCHIVES

16 Institutions Win NCI Awards for Phase I Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

Time Spent Sitting Associated With Total Mortality, Study Finds

July 30, 2010

Oncotype DX Cancer Test Can Predict Recurrence

November 25, 2011

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

Funding opportunities listed.

May 28, 2004

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993